AngioDynamics Revenue and Competitors

Latham, NY USA

Location

$9M

Total Funding

Estimated Revenue & Valuation

  • AngioDynamics's estimated annual revenue is currently $297.8M per year.(i)
  • AngioDynamics's estimated revenue per employee is $315,424
  • AngioDynamics's total funding is $9M.
  • AngioDynamics's current valuation is $874.7M. (January 2022)

Employee Data

  • AngioDynamics has 944 Employees.(i)
  • AngioDynamics grew their employee count by 0% last year.

AngioDynamics's People

NameTitleEmail/Phone
1
Sr. VP, GM, Global Vascular Interventional & TherapiesReveal Email/Phone
2
Regional VP Commercial Operations & Business DevelopmentReveal Email/Phone
3
VP, Global ProcurementReveal Email/Phone
4
VP, IT Enterprise SystemsReveal Email/Phone
5
VP, Research and DevelopmentReveal Email/Phone
6
SVP, Global Operations and R&DReveal Email/Phone
7
SVP, Quality & Regulatory AffairsReveal Email/Phone
8
VP Sales, Endovascular TherapiesReveal Email/Phone
9
SVP, Business DevelopmentReveal Email/Phone
10
SVP ITReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$160M8004%$323.5MN/A
#2
$9.3M3712%N/AN/A
#3
$36.4M1452%N/AN/A
#4
$7M280%N/AN/A
#5
$1M4-88%N/AN/A
#6
$7.5M21-9%$6.5MN/A
#7
$6M244%N/AN/A
#8
$13.1M524%N/AN/A
#9
$17.1M68-17%N/AN/A
#10
$27.9M1114%N/AN/A
Add Company

What Is AngioDynamics?

AngioDynamics, Inc. is a leading provider of innovative medical devices used by interventional radiologists, vascular surgeons and other physicians for the minimally invasive diagnosis and treatment of peripheral vascular disease. AngioDynamics designs, develops, manufactures and markets a broad line of therapeutic and diagnostic devices that enable interventional physicians, such as interventional radiologists, vascular surgeons and others, to treat peripheral vascular diseases and other non-coronary diseases. The company's diverse product line includes angiographic products and accessories, dialysis products, vascular access products, PTA products, drainage products, thrombolytic products and venous products.

keywords:N/A

$9M

Total Funding

944

Number of Employees

$297.8M

Revenue (est)

0%

Employee Growth %

$874.7M

Valuation

N/A

Accelerator

AngioDynamics News

2022-04-19 - AngioDynamics (NASDAQ:ANGO) Updates FY 2022 Earnings ...

AngioDynamics's revenue for the quarter was up 3.9% on a year-over-year basis. Equities research analysts expect that AngioDynamics will post -...

2022-04-06 - AngioDynamics Reports Fiscal 2022 Third Quarter Financial ...

In this news release, AngioDynamics has reported adjusted EBITDA, adjusted net income and adjusted earnings per share. Management uses these...

2022-04-06 - AngioDynamics to Present at the Needham Virtual Healthcare ...

AngioDynamics is a leading and transformative medical technology company focused on restoring healthy blood flow in the body's vascular system...

2021-08-12 - AngioDynamics : Receives FDA Approval for PRESERVE Study

Study Will Assess Use of NanoKnife System in Prostate Tissue Ablation Latham, New York, August 11, 2021 - AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, has received approva ...

2019-10-04 - AngioDynamics Buys Eximo Medical, for Up To 66M

AngioDynamics, Inc. (NASDAQ: ANGO), a Latham, NY-based provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, acquired Eximo Medical, Ltd., a Rehovot, Israel-based early commercial stage, medical device company, and its propriet ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$75M16718%N/A
#2
$300M22378%$5.4B